Epaminurad
Epaminurad (UR-1102) is an orally active, potent and selective URAT1 (urate transporter 1) inhibitor, with a Ki of 0.057 μM. Epaminurad quite modestly inhibits OAT1 and OAT3 (organic anion transporter) . Epaminurad is a uricosuric agent. Epaminurad can be used for gout and hyperuricemia research[1].
Product Specifications
CAS Number
1198153-15-9
Product Name Alternative
UR-1102; URC-102
UNSPSC
12352005
Target
OAT; URAT1
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/epaminurad.html
Purity
99.75
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1C2=C(OCC1)C=CN=C2)C3=CC(Br)=C(C(Br)=C3)O
Molecular Formula
C14H10Br2N2O3
Molecular Weight
414.05
References & Citations
[1]Ahn SO, et al. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone. J Pharmacol Exp Ther. 2016 Apr;357 (1) :157-66.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC202955L3V 200 µL
PLA2G12A (NM_030821) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
bsm-61278R-BF680-TR 20 µL
NSD3 Recombinant Antibody, AbBy Fluor™ 680 Conjugated
Sign In for Pricing
View Details 
MBS1091090-01 0.02 mg (E-Coli)
Recombinant Thalassiosira pseudonana ATP synthase subunit delta, chloroplastic (atpD)
Sign In for Pricing
View Details